Cargando…

PPARδ as a Metabolic Initiator of Mammary Neoplasia and Immune Tolerance

PPARδ is a ligand-activated nuclear receptor that regulates the transcription of genes associated with proliferation, metabolism, inflammation, and immunity. Within this transcription factor family, PPARδ is unique in that it initiates oncogenesis in a metabolic and tissue-specific context, especial...

Descripción completa

Detalles Bibliográficos
Autor principal: Glazer, Robert I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5203902/
https://www.ncbi.nlm.nih.gov/pubmed/28077942
http://dx.doi.org/10.1155/2016/3082340
_version_ 1782489813943844864
author Glazer, Robert I.
author_facet Glazer, Robert I.
author_sort Glazer, Robert I.
collection PubMed
description PPARδ is a ligand-activated nuclear receptor that regulates the transcription of genes associated with proliferation, metabolism, inflammation, and immunity. Within this transcription factor family, PPARδ is unique in that it initiates oncogenesis in a metabolic and tissue-specific context, especially in mammary epithelium, and can regulate autoimmunity in some tissues. This review discusses its role in these processes and how it ultimately impacts breast cancer.
format Online
Article
Text
id pubmed-5203902
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-52039022017-01-11 PPARδ as a Metabolic Initiator of Mammary Neoplasia and Immune Tolerance Glazer, Robert I. PPAR Res Review Article PPARδ is a ligand-activated nuclear receptor that regulates the transcription of genes associated with proliferation, metabolism, inflammation, and immunity. Within this transcription factor family, PPARδ is unique in that it initiates oncogenesis in a metabolic and tissue-specific context, especially in mammary epithelium, and can regulate autoimmunity in some tissues. This review discusses its role in these processes and how it ultimately impacts breast cancer. Hindawi Publishing Corporation 2016 2016-12-18 /pmc/articles/PMC5203902/ /pubmed/28077942 http://dx.doi.org/10.1155/2016/3082340 Text en Copyright © 2016 Robert I. Glazer. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Glazer, Robert I.
PPARδ as a Metabolic Initiator of Mammary Neoplasia and Immune Tolerance
title PPARδ as a Metabolic Initiator of Mammary Neoplasia and Immune Tolerance
title_full PPARδ as a Metabolic Initiator of Mammary Neoplasia and Immune Tolerance
title_fullStr PPARδ as a Metabolic Initiator of Mammary Neoplasia and Immune Tolerance
title_full_unstemmed PPARδ as a Metabolic Initiator of Mammary Neoplasia and Immune Tolerance
title_short PPARδ as a Metabolic Initiator of Mammary Neoplasia and Immune Tolerance
title_sort pparδ as a metabolic initiator of mammary neoplasia and immune tolerance
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5203902/
https://www.ncbi.nlm.nih.gov/pubmed/28077942
http://dx.doi.org/10.1155/2016/3082340
work_keys_str_mv AT glazerroberti ppardasametabolicinitiatorofmammaryneoplasiaandimmunetolerance